EXAGEN INC. Shareholders' Equity
EXAGEN INC. (XGN) had Shareholders' Equity of $12.22 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.22M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $14.43M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $17.45M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $18.14M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $12.22M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $14.43M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $17.45M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $18.14M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $21.03M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $6.40M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $9.54M 10-Q · filed 2026-08-04 | |
| 2024-09-30 | $12.87M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $17.59M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $19.99M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $22.69M 10-K · filed 2026-03-10 | |
| 2023-09-30 | $27.50M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $31.90M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $35.94M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $42.46M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $56.19M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $62.82M 10-Q · filed 2023-11-13 | $64.18M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $76.16M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $84.94M 10-K · filed 2024-03-18 | |
| 2021-09-30 | $90.80M 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $96.38M 10-Q/A · filed 2022-11-21 | |
| 2021-03-31 | $101.47M 10-Q/A · filed 2022-11-21 | |
| 2020-12-31 | $41.84M 10-K · filed 2023-03-20 | |
| 2020-09-30 | $44.47M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $47.84M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $50.54M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $55.66M 10-K · filed 2022-03-22 | |
| 2019-09-30 | $58.65M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$121.73M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | -$116.77M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | -$111.97M 10-K · filed 2021-03-16 | |
| 2018-09-30 | -$107.81M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$103.29M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | -$98.88M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | -$96.68M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |